Enovis ROE 2010-2023 | ENOV
Enovis ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $-0.03B | $3.42B | -0.96% |
2023-09-30 | $-0.08B | $3.44B | -2.18% |
2023-06-30 | $-0.14B | $3.45B | -4.04% |
2023-03-31 | $-0.05B | $3.45B | -1.51% |
2022-12-31 | $-0.01B | $3.45B | -0.37% |
2022-09-30 | $0.02B | $3.41B | 0.57% |
2022-06-30 | $0.12B | $3.49B | 2.66% |
2022-03-31 | $0.07B | $4.64B | 1.49% |
2021-12-31 | $0.07B | $4.66B | 1.61% |
2021-09-30 | $0.11B | $4.63B | 2.54% |
2021-06-30 | $0.09B | $4.35B | 2.40% |
2021-03-31 | $0.06B | $4.29B | 1.55% |
2020-12-31 | $0.04B | $3.59B | 1.22% |
2020-09-30 | $-0.01B | $3.46B | -0.23% |
2020-06-30 | $-0.01B | $3.40B | -0.33% |
2020-03-31 | $-0.47B | $3.34B | -14.28% |
2019-12-31 | $-0.53B | $3.49B | -15.51% |
2019-09-30 | $-0.47B | $3.13B | -13.67% |
2019-06-30 | $-0.44B | $3.26B | -12.73% |
2019-03-31 | $0.06B | $3.74B | 1.77% |
2018-12-31 | $0.14B | $3.48B | 3.91% |
2018-09-30 | $0.11B | $3.48B | 2.93% |
2018-06-30 | $0.12B | $3.54B | 3.34% |
2018-03-31 | $0.14B | $3.84B | 3.79% |
2017-12-31 | $0.15B | $3.73B | 4.37% |
2017-09-30 | $0.18B | $3.51B | 5.34% |
2017-06-30 | $0.16B | $3.37B | 4.92% |
2017-03-31 | $0.15B | $3.21B | 4.59% |
2016-12-31 | $0.13B | $3.09B | 4.08% |
2016-09-30 | $0.14B | $3.17B | 4.21% |
2016-06-30 | $0.13B | $3.16B | 3.86% |
2016-03-31 | $0.14B | $3.24B | 4.17% |
2015-12-31 | $0.17B | $3.26B | 5.05% |
2015-09-30 | $0.20B | $3.30B | 6.09% |
2015-06-30 | $0.26B | $3.43B | 7.61% |
2015-03-31 | $0.40B | $3.25B | 11.52% |
2014-12-31 | $0.37B | $3.35B | 10.62% |
2014-09-30 | $0.33B | $3.54B | 9.76% |
2014-06-30 | $0.30B | $3.65B | 9.78% |
2014-03-31 | $0.16B | $3.40B | 5.87% |
2013-12-31 | $0.16B | $2.74B | 6.46% |
2013-09-30 | $0.14B | $2.57B | 6.00% |
2013-06-30 | $0.09B | $2.40B | 4.18% |
2013-03-31 | $0.05B | $2.06B | 2.16% |
2012-12-31 | $-0.08B | $2.16B | -3.83% |
2012-09-30 | $-0.11B | $2.18B | -6.81% |
2012-06-30 | $-0.11B | $2.10B | -9.58% |
2012-03-31 | $-0.11B | $2.22B | -15.27% |
2011-12-31 | $0.01B | $0.19B | 2.16% |
2011-09-30 | $0.03B | $0.25B | 12.59% |
2011-06-30 | $0.03B | $0.25B | 13.70% |
2011-03-31 | $0.02B | $0.24B | 11.10% |
2010-12-31 | $0.02B | $0.22B | 8.29% |
2010-09-30 | $0.02B | $0.23B | 7.31% |
2010-06-30 | $0.02B | $0.19B | 7.58% |
2010-03-31 | $0.02B | $0.19B | 8.61% |
2009-12-31 | $0.02B | $0.22B | 12.53% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.030B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
Axonics (AXNX) | United States | $3.401B | 0.00 |
10x Genomics (TXG) | United States | $3.288B | 0.00 |
Azenta (AZTA) | United States | $2.910B | 237.18 |
Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
Privia Health (PRVA) | United States | $2.167B | 96.11 |
Schrodinger (SDGR) | United States | $1.733B | 0.00 |
Omnicell (OMCL) | United States | $1.279B | 31.30 |
Phreesia (PHR) | United States | $1.162B | 0.00 |
Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
Standard BioTools (LAB) | United States | $0.708B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
Talkspace (TALK) | United States | $0.527B | 0.00 |
Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
Pulmonx (LUNG) | United States | $0.281B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.153B | 0.00 |
MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
Augmedix (AUGX) | United States | $0.139B | 0.00 |
Outset Medical (OM) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.03 |
111 (YI) | China | $0.086B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
Movano (MOVE) | United States | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |